Literature DB >> 23797699

Early major worsening in ischemic stroke: predictors and outcome.

G Ntaios, D Lambrou, D Cuendet, P Michel.   

Abstract

INTRODUCTION: We aimed to investigate the characteristics and outcome of patients suffering early major worsening (EMW) after acute ischemic stroke (AIS) and assess the parameters associated with it.
METHODS: All consecutive patients with AIS in the ASTRAL registry until 10/2010 were included. EMW was defined as an NIHSS increase of ≥8 points within the first 24 h after admission. The Bootstrap version of the Kolmogorov-Smirnov test and the χ(2)-test were used for the comparison of continuous and categorical covariates, respectively, between patients with and without EMW. Multiple logistic regression analysis was performed to identify independent predictors of EMW.
RESULTS: Among 2155 patients, 43 (2.0 %) had an EMW. EMW was independently associated with hemorrhagic transformation (OR 22.6, 95 % CI 9.4-54.2), cervical artery dissection (OR 9.5, 95 % CI 4.4-20.6), initial dysarthria (OR 3.7, 95 % CI 1.7-8.0), and intravenous thrombolysis (OR 2.1, 95 % CI 1.1-4.3), whereas a negative association was identified with initial eye deviation (OR 0.4, 95 % CI 0.2-0.9). Favorable outcome at 3 and 12 months was less frequent in patients with EMW compared to patients without (11.6 vs. 55.3 % and 16.3 vs. 50.7 %, respectively), and case fatality was higher (53.5 vs. 12.9 % and 55.8 vs. 16.8 %, respectively). Stroke recurrence within 3 months in surviving patients was similar between patients with and without EMW (9.3 vs. 9.0 %, respectively).
CONCLUSIONS: Worsening of ≥8 points in the NIHSS score during the first 24 h in AIS patients is related to cervical artery dissection and hemorrhagic transformation. It justifies urgent repeat parenchymal and arterial imaging. Both conditions may be influenced by targeted interventions in the acute phase of stroke.

Entities:  

Mesh:

Year:  2013        PMID: 23797699     DOI: 10.1007/s12028-013-9865-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  18 in total

1.  Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials.

Authors:  Maurizio Paciaroni; Giancarlo Agnelli; Sara Micheli; Valeria Caso
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

2.  Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project.

Authors:  H Tei; S Uchiyama; K Ohara; M Kobayashi; Y Uchiyama; M Fukuzawa
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

3.  The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging.

Authors:  Patrik Michel; Céline Odier; Matthieu Rutgers; Marc Reichhart; Philippe Maeder; Reto Meuli; Max Wintermark; Ali Maghraoui; Mohamed Faouzi; Alexandre Croquelois; George Ntaios
Journal:  Stroke       Date:  2010-10-07       Impact factor: 7.914

4.  Pattern of response of National Institutes of Health Stroke Scale components to early recanalization in the CLOTBUST trial.

Authors:  Robert Mikulik; Ladislav Dusek; Michael D Hill; Eva Fulep; James C Grotta; Marc Ribo; Carlos Molina; Andrei V Alexandrov
Journal:  Stroke       Date:  2010-02-04       Impact factor: 7.914

5.  Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis.

Authors:  D Toni; M Fiorelli; M Gentile; S Bastianello; M L Sacchetti; C Argentino; C Pozzilli; C Fieschi
Journal:  Arch Neurol       Date:  1995-07

6.  Acute seizures in acute ischemic stroke: does thrombolysis have a role to play?

Authors:  Vincent Alvarez; Andrea O Rossetti; Vasileios Papavasileiou; Patrik Michel
Journal:  J Neurol       Date:  2012-06-29       Impact factor: 4.849

7.  Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy.

Authors:  Richard Leigh; Osama O Zaidat; Muhammad F Suri; Gwendolyn Lynch; Sophia Sundararajan; Jeffrey L Sunshine; Robert Tarr; Warren Selman; Dennis M D Landis; Jose I Suarez
Journal:  Stroke       Date:  2004-06-03       Impact factor: 7.914

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

Review 9.  Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

Authors:  Manuel Yepes; Benoit D Roussel; Carine Ali; Denis Vivien
Journal:  Trends Neurosci       Date:  2008-10-27       Impact factor: 13.837

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  1 in total

1.  Anomalous equivalent potential temperature: an atmospheric feature predicting days with higher risk for fatal outcome in acute ischemic stroke-a preliminary study.

Authors:  András Folyovich; Dávid Biczó; Nadim Al-Muhanna; Anna K Béres-Molnár; Ádám Fejős; Ádám Pintér; Dániel Bereczki; Antal Fischer; Károly Vadasdi; Ferenc Pintér
Journal:  Environ Monit Assess       Date:  2015-08-02       Impact factor: 2.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.